Feedback #FDBK – Final results, notice of AGM and TexRAD® Lung CE mark update.
Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces its final results for the year ended 31 May 2017. Operational highlights (including post-period end)1 · Letter of Intent for TexRAD® Lung signed with a leading global medical imaging company · Exclusive TexRAD® distributor agreements signed in China and Korea · Prototype integration solution for TexRAD® demonstrated to Alliance Medical Group […]
Feedback Plc (FDBK) – Brand CEO Alan Green discusses developments on the Vox Markets podcast
Originally published on Wednesday April 5th 2017, Brand CEO Alan Green discusses the emergence of TexRAD texture analysis software as a benchmark medical imaging tool, and the Cadran image archiving system, developed by Cambridge Computed Imaging, in use at Papworth hospital. Both are systems are owned by Feedback (FDBK). Together with Justin Waite on the Vox Markets podcast, Alan discusses the […]
Feedback Chairman Dr Alastair Riddell discusses TexRAD Lung and other developments with Proactive’s Andrew Scott
Dr Alastair Riddell, chairman of Feedback (LON:FDBK) tells Proactive Investor’s Andrew Scott their TexRAD Lung product could soon be available on the diagnostic imaging platform of a leading global imaging company.
Daily Mail – SMALL CAP IDEAS: Feedback’s new chairman reveals pioneering cancer imaging program is proving a hit
From Daily Mail by Ian Lyall at Proactive Investors for ThisIsMoney Dr Alastair Riddell’s CV reveals a high-flying career with the forerunners of what are now GE Healthcare, Johnson & Johnson and Pfizer, followed by spells guiding businesses to IPO or trade sale. So, what attracted him to the challenge of Feedback, the Cambridge-based AIM-listed […]